Keywords: famvir, gains, once-daily, product, license, uk, smithkline

Famvir Gains Once-Daily Product license

Article | 18 September 1995

Print This

In the UK, SmithKline Beecham's antiviral drug Famvir (famciclovir) has had a modification to its product license which notes that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in